MedPath

PROPAIRA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

TGA:13

Drug Approvals

PROPAIRA FLUID SUNSCREEN SPF50+ (467786)

Product Name
PROPAIRA FLUID SUNSCREEN SPF50+
Approval Date
Nov 8, 2024
TGA

PROPAIRA REFLEKTA PHYSICAL FLUID SUNSCREEN SPF50 (454306)

Product Name
PROPAIRA REFLEKTA PHYSICAL FLUID SUNSCREEN SPF50
Approval Date
Jul 3, 2024
TGA

SKIN FORCE PLUS RESVERATROL & TUMERIC (445777)

Product Name
SKIN FORCE PLUS RESVERATROL & TUMERIC
Approval Date
Apr 16, 2024
TGA

PROPAIRA NAD 100 (433072)

Product Name
PROPAIRA NAD 100
Approval Date
Jan 9, 2024
TGA

MICROBIOME GUT-SKIN PROBIOTICS (421684)

Product Name
MICROBIOME GUT-SKIN PROBIOTICS
Approval Date
Sep 12, 2023
TGA

PROPAIRA HAIR REVITALISING PLUS CAPSULES (412534)

Product Name
PROPAIRA HAIR REVITALISING PLUS CAPSULES
Approval Date
Jul 5, 2023
TGA

PROPAIRA MINERAL SUNSCREEN SPF 40 (382455)

Product Name
PROPAIRA MINERAL SUNSCREEN SPF 40
Approval Date
Jan 11, 2022
TGA

PROPAIRA HAIR BOOSTER PLUS CAPSULES (365279)

Product Name
PROPAIRA HAIR BOOSTER PLUS CAPSULES
Approval Date
May 11, 2021
TGA

500 mg NICOTINAMIDE (330146)

Product Name
500 mg NICOTINAMIDE
Approval Date
Feb 18, 2020
TGA

PROPAIRA DRY TOUCH SUNSCREEN SPF50+ (316146)

Product Name
PROPAIRA DRY TOUCH SUNSCREEN SPF50+
Approval Date
Apr 4, 2019
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.